Use of other anti-dementia drugs

PheWeb

ADMED_OTHER_ANTI_DEMENTIA_DRUGS

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC N06DX

5350

Check pre-conditions, main-only, mode, ICD version None

4445

Check minimum number of events

Min. number of events 3

4445

Include endpoints None

4445

ADMED_OTHER_ANTI_DEMENTIA_DRUGS

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Use of other anti-dementia drugs based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Use of memantine

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	4274	1981	2293
Unadjusted prevalence (%)	1.39	1.14	1.70
Mean age at first event (years)	79.53	79.72	79.37

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.10	7.64 [6.14, 9.50]	1.5e-74	1617
15 years	0.01	1.95 [1.56, 2.45]	7.3e-9	396
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: ADMED_OTHER_ANTI_DEMENTIA_DRUGS – Use of other anti-dementia drugs
GWS hits:

Survival analyses between endpoints

↥

Plot

before Use of other anti-dementia drugs
after Use of other anti-dementia drugs

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Use of other anti-dementia drugs

↥